Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Multicentre Randomised Phase II Study of AZD1775 plus Chemotherapy Versus Chemotherapy Alone in Patients with Platinum-Resistant TP53-Mutated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
IRB GYN49
CC 15-374
Hospital Fairview, Hillcrest, Main Campus
Phase Phase 2
Disease Gynecologic
Drug AZD1775
